EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

M6A demethylase ALKBH5 mediated Igfbp4 mRNA m6A modification drives fibroblast activation and pathological upper airway fibrosis

Jing Wang, Ziwei Liao, Mengrou Xu iD, Yangyang Zheng, Bin Hu, Qianhui Xia, Hongming Xu

Clinical and Translational Medicine · 2026-04 · 16 (4)

DOI: 10.1002/ctm2.70656 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Medicine, online erschienen am 21.04.2026. Verfasst von Jing Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology Head and Neck Surgery, Shanghai Children's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Pe…. Hauptthemen laut MEDLINE: AlkB Homolog 5, RNA Demethylase, Fibrosis, Fibroblasts. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Laryngotracheal stenosis (LTS) is a fibroproliferative disease of the upper airway characterised by dysregulated extracellular matrix deposition and fibroblast activation. AlkB Homologue 5 (ALKBH5) has emerged as a key regulator of disease pathogenesis by modulating mRNA stability, yet its role in LTS remains unclear.

Methods

We established a LTS rat model and observed mRNA m6A methylation and m6A demethylase ALKBH5 in stenotic tissues. Using single‐cell RNA sequencing, in vivo ALKBH5 knockout models, and in vitro gain‐ and loss‐of‐function assays, we explored the role of ALKBH5 in fibroblast activation and fibrosis. The downstream target of ALKBH5 and its underlying molecular mechanism were identified through integrating RNA‐seq and MeRIP‐seq analyses, and further validated by RNA immunoprecipitation (RIP)‐quantitative PCR (qPCR), dual‐luciferase reporter assays, and in vitro gain‐ and loss‐of‐function experiments. In addition, the therapeutic potential of exogenous modulation of ALKBH5 target was evaluated in LTS models.

Results

ALKBH5 acted as a key pro‐fibrotic regulator by enhancing the expression of COL1A1, COL3A1 and alpha‐smooth muscle actin (α‐SMA), increasing fibroblast contractility, and promoting airway fibrosis progression in LTS. RNA‐seq and MeRIP‐seq analyses identified Igfbp4 as a direct target of ALKBH5. RIP‐qPCR and luciferase reporter assay confirmed ALKBH5 binding to the 3′‐untranslated region of Igfbp4 . Functional studies revealed that IGFBP4 inhibited β‐catenin signalling and attenuated fibroblast activation. Overexpression of IGFBP4 partly reversed the profibrotic effects of ALKBH5, both in vitro and in vivo, significantly reducing collagen deposition and airway narrowing in LTS rats.

Conclusion

Our findings identify a novel ALKBH5–IGFBP4 regulatory axis that drives fibroblast activation and airway fibrosis in LTS. Targeting ALKBH5 or supplementing IGFBP4 may become novel therapeutic strategies for LTS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlkB Homolog 5, RNA DemethylaseFibrosisFibroblastsAnimalsRatsHumansDisease Models, AnimalRNA MethylationRNA, MessengerMale

Stichwörter der Autor:innen

ALKBH5IGFBP4airway fibrosislaryngotrachealm6A

Substanzen

AlkB Homolog 5, RNA DemethylaseALKBH5 protein, humanRNA, Messenger

Autor:innen und Institutionen

  • Department of Otorhinolaryngology Head and Neck Surgery, Shanghai Children's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
  • ENT Institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, People's Republic of China.

ORCID-Profile: Mengrou Xu

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wang, J., Liao, Z., Xu, M., Zheng, Y., Hu, B., Xia, Q., & Xu, H. (2026). M6A demethylase ALKBH5 mediated Igfbp4 mRNA m6A modification drives fibroblast activation and pathological upper airway fibrosis. Clinical and Translational Medicine, 16(4). https://doi.org/10.1002/ctm2.70656

Vancouver

Wang J, Liao Z, Xu M, Zheng Y, Hu B, Xia Q, et al. M6A demethylase ALKBH5 mediated Igfbp4 mRNA m6A modification drives fibroblast activation and pathological upper airway fibrosis. Clinical and Translational Medicine. 2026;16(4). doi:10.1002/ctm2.70656

BibTeX
@article{Wang2026,
  author = {Wang, Jing and Liao, Ziwei and Xu, Mengrou and Zheng, Yangyang and Hu, Bin and Xia, Qianhui and Xu, Hongming},
  title = {M6A demethylase ALKBH5 mediated Igfbp4 mRNA m6A modification drives fibroblast activation and pathological upper airway fibrosis},
  journal = {Clinical and Translational Medicine},
  year = {2026},
  volume = {16},
  number = {4},
  doi = {10.1002/ctm2.70656}
}
Kostenlos starten →